BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 21482982)

  • 21. [Clinical diagnostic imaging (including FDG-PET/CT)].
    Torizuka T
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():198-201. PubMed ID: 23133952
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of FDG-PET and bone marrow examination in lymphoma staging.
    El-Najjar I; Barwick T; Avril N; Montoto S
    Ann Oncol; 2012 Sep; 23 Suppl 10():x89-91. PubMed ID: 22987999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The progress of laboratory medicine and diagnostic procedures in lymphoma and its future prospects].
    Okamoto M
    Nihon Rinsho; 2014 Mar; 72(3):391-8. PubMed ID: 24724393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 18F-FDG-PET/CT in staging, recurrence detection and response evaluation of primary splenic lymphoma with eight years follow up.
    Karunanithi S; Roy SG; Murugan V; Bal C; Kumar R
    Nucl Med Rev Cent East Eur; 2015; 18(1):37-8. PubMed ID: 25633516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical impact of contrast-enhanced computed tomography combined with low-dose (18)F-fluorodeoxyglucose positron emission tomography/computed tomography on routine lymphoma patient management.
    Chalaye J; Luciani A; Enache C; Beaussart P; Lhermite C; Evangelista E; Sasanelli M; Safar V; Meignan M; Haioun C; Rahmouni A; Itti E
    Leuk Lymphoma; 2014 Dec; 55(12):2887-92. PubMed ID: 24597987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of FDG-PET scans in patients with lymphoma.
    Seam P; Juweid ME; Cheson BD
    Blood; 2007 Nov; 110(10):3507-16. PubMed ID: 17709603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The role of positron emission tomography in in lymphoma diagnosis and treatment].
    Papamichael DC; Pianou NK; Chatzipavlidou V
    Hell J Nucl Med; 2015; 18(2):173-9. PubMed ID: 26187221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positron emission tomography and gallium metabolic imaging in lymphoma.
    Coiffier B
    Curr Oncol Rep; 2001 May; 3(3):266-70. PubMed ID: 11296138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PET-CT in Staging, Response Evaluation, and Surveillance of Lymphoma.
    Thanarajasingam G; Bennani-Baiti N; Thompson CA
    Curr Treat Options Oncol; 2016 May; 17(5):24. PubMed ID: 27032646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leukemia and lymphoma.
    Guillerman RP; Voss SD; Parker BR
    Radiol Clin North Am; 2011 Jul; 49(4):767-97, vii. PubMed ID: 21807173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positron emission tomography and lymphoma therapy.
    Golder W
    Onkologie; 2001 Oct; 24(5):496-8. PubMed ID: 11694779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of FDG PET in the management of childhood lymphomas--case proven or is the jury still out?
    Shankar A; Fiumara F; Pinkerton R
    Eur J Cancer; 2008 Mar; 44(5):663-73. PubMed ID: 18313916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FDG-PET scans in patients with lymphoma.
    Elstrom RL; Leonard JP
    Curr Hematol Malig Rep; 2008 Oct; 3(4):197-203. PubMed ID: 20425466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positron emission tomography imaging for lymphoma.
    Jerusalem G; Hustinx R; Beguin Y; Fillet G
    Curr Opin Oncol; 2005 Sep; 17(5):441-5. PubMed ID: 16093792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gallium-67 scintigraphy: a cornerstone in functional imaging of lymphoma.
    Even-Sapir E; Israel O
    Eur J Nucl Med Mol Imaging; 2003 Jun; 30 Suppl 1():S65-81. PubMed ID: 12644887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Revised staging system for malignant lymphoma based on the Lugano classification.
    Munakata W; Terauchi T; Maruyama D; Nagai H
    Jpn J Clin Oncol; 2019 Oct; 49(10):895-900. PubMed ID: 31504700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gallium-67 imaging in lymphoma: tricks of the trade.
    Morton KA; Jarboe J; Burke EM
    J Nucl Med Technol; 2000 Dec; 28(4):221-32. PubMed ID: 11142323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Imaging of Lymphoma: Future Directions and Perspectives.
    Pomykala KL; Fendler WP; Vermesh O; Umutlu L; Herrmann K; Seifert R
    Semin Nucl Med; 2023 May; 53(3):449-456. PubMed ID: 36344325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Management of Aggressive Non-Hodgkin's B-Cell Lymphoma.
    Shelly MJ; McDermott S; O'Connor OJ; Blake MA
    ISRN Hematol; 2012; 2012():456706. PubMed ID: 22474590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Report on the 4th International Workshop on Positron Emission Tomography in Lymphoma held in Menton, France, 3-5 October 2012.
    Meignan M; Barrington S; Itti E; Gallamini A; Haioun C; Polliack A
    Leuk Lymphoma; 2014 Jan; 55(1):31-7. PubMed ID: 23763460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.